Loading...
*  Portopulmonary hypertension
Epoprostenol therapy can lower PAP by 29-46% and PVR by 21-71%., Ilioprost shows no evidence of generating tolerance, increases ... Epoprostenol and ilioprost (a more stable, longer acting variation) can and does successfully bridge for patients to transplant ... Successful use of chronic epoprostenol as a bridge to liver transplant in severe PPHTN. Transplant 1998 4:457 Kuo PC, Johnson ... Prostacyclin - PGI2, an arachadonic acid derived lipid mediator (Epoprostenol, Flolan, Treprostenil) - is a vasodilator and, at ...
*  DMOZ - Health: Pharmacy: Drugs and Medications: E: Epoprostenol
Epoprostenol is a drug used in the treatment of Primary Pulmonary Hypertension. It is administered continuously by a pump. ... Epoprostenol is a drug used in the treatment of Primary Pulmonary Hypertension. It is administered continuously by a pump. ...
*  Prostacyclin
But, as with native prostacyclin, the structure of the epoprostenol molecule proved to be unstable in solution, prone to rapid ... When used as a drug, it is also known as epoprostenol. The terms are sometimes used interchangeably. Prostacyclin (PGI2) ... No evidence of platelet dysfunction or an increase in surgical bleeding after administration of inhaled epoprostenol has been ... The research team synthesized nearly 1,000 analogues.[citation needed] Essential fatty acid "epoprostenol" at Dorland's Medical ...
*  Prostacyclin receptor
Major drugs in this category include PGI2 itself (i.e. epoprostenol), iloprost, treprostinil, and beraprost with epoprostenol ... Epoprostenol causes improvements in hemodynamic parameters and oxygenation in patients suffering the acute respiratory distress ... McGinn K, Reichert M (January 2016). "A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary ... Sitbon O, Vonk Noordegraaf A (January 2017). "Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience ...
*  Harrison Farber
Sarcoidosis associated pulmonary hypertension: Outcome with long-term epoprostenol treatment (submitted). Klings ES, Odhiambo, ...
*  Treprostinil
epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension". Curr Med Res ... But like native prostacyclin, the structure of the epoprostenol molecule proved to be unstable in solution, prone to rapid ... In patients with pulmonary arterial hypertension requiring transition from epoprostenol sodium (Flolan), treprostinil is ... The collaboration produced a synthetic molecule which was given the name epoprostenol. ...
*  Selexipag
Epoprostenol, another name for prostacyclin Analogues of prostacyclin: Beraprost Iloprost Treprostinil Sitbon, O.; Morrell, N ...
*  Systemic scleroderma
Pulmonary hypertension may be treated with epoprostenol, treprostinil, bosentan and possibly aerolized iloprost. Systemic ...
*  Eicosanoid
Cruz JE, Ward A, Anthony S, Chang S, Bae HB, Hermes-DeSantis ER (2016). "Evidence for the Use of Epoprostenol to Treat ...
*  Gilead Sciences
Under an agreement with GlaxoSmithKline, Myogen marketed Flolan (epoprostenol sodium) in the United States for the treatment of ...
*  List of GlaxoSmithKline products
... epoprostenol) Flovent (fluticasone propionate) Fortum (ceftazidime) Horizant (gabapentin enacarbil) Hycamtin (topotecan) ...
*  List of drugs: Em-Ep
... epoprostenol (INN) epostane (INN) eprazinone (INN) epratuzumab (INN) eprinomectin (INN) epristeride (INN) eprobemide (INN) ...
*  Actelion
Veletri (epoprostenol for injection): is approved by the U.S. Food and Drug Administration (FDA) for the long-term intravenous ...
*  List of MeSH codes (D10)
... epoprostenol MeSH D10.251.355.255.100.825 --- thromboxanes MeSH D10.251.355.255.100.825.800 --- thromboxane a2 MeSH D10.251. ... epoprostenol MeSH D10.251.355.255.550.700 --- prostaglandins, synthetic MeSH D10.251.355.255.550.700.125 --- iloprost MeSH ...
*  Teva Pharmaceutical Industries
Daunorubicin Dexmethylphenidate Dextroamphetamine Diazepam Dihydrocodeine Doxorubicin HCl Enpresse Epirubicin HCl Epoprostenol ...
*  Respiratory Pharmacology
Epoprostenol Kester, [edited by] Robert L. Wilkins, James K. Stoller, Robert M. Kacmarek ; consulting editors, David C. ...
*  ATC code B01
B01AC05 Ticlopidine B01AC06 Acetylsalicylic acid B01AC07 Dipyridamole B01AC08 Carbasalate calcium B01AC09 Epoprostenol B01AC10 ...
*  List of MeSH codes (D23)
... epoprostenol MeSH D23.469.050.175.800 --- thromboxanes MeSH D23.469.050.175.800.800 --- thromboxane a2 MeSH D23.469.050.175. ...
*  List of MeSH codes (D12.776.543)
... epoprostenol MeSH D12.776.543.750.075.700.600 -- receptors, prostaglandin e MeSH D12.776.543.750.075.700.800 -- receptors, ... epoprostenol MeSH D12.776.543.750.100.200.700.600 -- receptors, prostaglandin e MeSH D12.776.543.750.100.200.700.800 -- ...
*  Antiplatelet drug
Epoprostenol is a prostacyclin that is used to inhibit platelet aggregation during renal dialysis (with or without heparin) and ...